Screener
Iovance Biotherapeutics, Inc. IOVA Operating Lease Liabilities (Total)
Operating Lease Liabilities (Total) at other companies
Other financials
Where this comes from
Reported directly by Iovance Biotherapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OperatingLeaseLiability.
The source filing: Iovance Biotherapeutics, Inc.’s 10-Q, filed August 6, 2026.
- Filed
- Aug 6, 2026, 9:15 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001104659-26-091716
| Line item | June 30, 2026 | December 31, 2025 |
|---|---|---|
| Operating lease right-of-use assets | $43,480 | $45,899 |
| Operating lease liabilities | ||
| Current portion included in current liabilities | $2,673 | $4,043 |
| Long-term portion included in non-current liabilities | 43,330 | 44,401 |
| Total operating lease liabilities | $46,003 | $48,444 |
Item 1.Condensed Consolidated Financial Statements (Unaudited)
FAQ
- What is Iovance Biotherapeutics, Inc.'s operating lease liabilities (total)?
- Iovance Biotherapeutics, Inc. (IOVA) reported operating lease liabilities (total) of $46M in Q2 2026.
- How has Iovance Biotherapeutics, Inc.'s operating lease liabilities (total) changed year-over-year?
- Iovance Biotherapeutics, Inc.'s operating lease liabilities (total) decreased by 11.8% year-over-year, from $52.17M to $46M.
- What is the long-term trend for Iovance Biotherapeutics, Inc.'s operating lease liabilities (total)?
- Over 5 years (2020 to 2025), Iovance Biotherapeutics, Inc.'s operating lease liabilities (total) has grown at a -1.3% compound annual growth rate (CAGR), from $51.66M to $48.44M.
- What does operating lease liabilities (total) mean?
- This represents the total present value of future lease payments for operating leases, recognized as a liability on the balance sheet. It reflects the company's long-term commitment to leased assets such as office space, warehouses, and equipment. Tracking this helps investors evaluate the company's off-balance-sheet financing obligations and overall debt-like commitments.
Ask your AI about Iovance Biotherapeutics, Inc.'s operating lease liabilities (total).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude